HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Prefe... ( BIRMINGHAM Ala. Sept. 14 /- Hea...)

HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock

Date:9/14/2009

BIRMINGHAM, Ala., Sept. 14 /PRNewswire-FirstCall/ -- HealthSouth Corporation (NYSE: HLS) announced today that its board of directors has declared a regular quarterly dividend of $16.25 per share on its 6.5% Series A Convertible Perpetual Preferred Stock, payable on Oct. 15, 2009, to holders of record on Oct. 1, 2009.

About HealthSouth

HealthSouth is the nation's largest provider of inpatient rehabilitative healthcare services. Operating in 26 states across the country and in Puerto Rico, HealthSouth serves patients through its network of inpatient rehabilitation hospitals, long-term acute care hospitals, outpatient rehabilitation satellites, and home health agencies. HealthSouth strives to be the nation's preeminent provider of inpatient rehabilitative healthcare services and can be found on the Web at www.healthsouth.com.

    Media Contact
    Andy Brimmer, 205-410-2777
    Investor Relations Contact
    Mary Ann Arico, 205-969-6175
    maryann.arico@healthsouth.com

SOURCE HealthSouth Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:11/24/2009)... Physician recruiting firm LocumTe...n staffing, is pleased to announce its agreement w...ovide physicians for locum tenens assignments. , ...ember 24, 2009 -- Physician recruiting firm Loc...sician staffing, is pleased to announce its agreem...

(Date:11/24/2009)...T.CLEMENS,Mich.,Nov.24/PRNewswire/--Mostpeoplelook...gdinner,gettingtogetherwithfriendsandfamily.TheMac...mily,shealthduringtheholidays.Travelingandbeinginl...berthesestepstostayhealthy: ,, VACCINATION ,...gh-riskcategoriestogetvaccinatedagainsttheH1N1stra...

(Date:11/24/2009)...ANTACLARA,Calif.,Nov.24/PRNewswire/--AgitoNetworks...erprisemobility,todayannouncedthatitwashonoredinth...AgitoRoamAnywhereMobilityRouterv3.0.EverythingChan...thathaveintroducednewsolutionsthatdriveadvancesthr...el,sTestCenterreviewedhundredsofapplicationsforthe...

(Date:11/24/2009)...HEATON,Ill.,Nov.24/PRNewswire-USNewswire/--Dr.Nels...asbeennamedtherecipientoftheJamesBradyAward.Theawa...)ofIllinoisduringtheirannualconferenceonOctober30,...wasgiventheawardinrecognitionofhisexpertiseinaddre...compassionatetreatmentandexceptionalcareofhispatie...

(Date:11/24/2009)...IRMINGHAM,Ala.,Nov.24/PRNewswire-FirstCall/--Healt...articipateintheBankofAmericaMerrillLynch2009Credit...thSeniorVicePresidentandTreasurerEdFaywillbespeaki...onwillbewebcastliveandwillbeavailableat http://inv... ,, AboutHealthSouth ,, HealthSouthisthena...

Breaking Medicine News(10 mins):Health News:VHA Names LocumTenens.com as Preferred Physician Staffing Vendor 2 Health News:Tips To Enjoy a Flu-Free Holiday Season 2 Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 2 Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 3 Health News:Marianjoy Medical Group Physician Receives James Brady Award 2

[1] VHA Names LocumTenens.com as Preferred Physician Staffing Vendor [2] Tips To Enjoy a Flu-Free Holiday Season [2] Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel [0] Marianjoy Medical Group Physician Receives James Brady Award [0] HealthSouth To Present at Bank of America Merrill Lynch 2009 Credit Conference

...d (ASX: TEO), a global healthcare company, announc...pheral IV catheter it is developing with Vascular ...Science Invention Award. , "Telesso is pleased to...Stacks. "Attempts to start an IV frequently fail, ...

...discussion about trade-offs , , STANFORD, Calif.,... about the trade-offs involved in health care refo...anford Center on Longevity (SCL). , , The finding...the public. , , "As lawmakers are preparing large...

... Holdings, Inc. (NYSE: ZMH ; SWX: ZMH) announced...nk 34th Annual Health Care Conference in Boston, M...n Time. , , A live webcast of the presentation ca...erence. , , About the Company , Founded in 1927...

... Johnson & Johnson (NYSE: JNJ ) will partici...Conference on Tuesday, May 19th, at the InterConti...wide Chairman, Pharmaceuticals Group for Johnson &...stors and parties by accessing the Johnson & J...

...cs, Inc. announces that it has enrolled its 1,000t...AS ( G auging R esponsiveness with A V erifyNow(... The trial is specifically designed to demonstrate...ebo controlled trial will determine whether tailor...

..., May 13 /PRNewswire-Asia-FirstCall/ -- Shengtai,P...hengtai" or "the Company"),a leading manufacturer ...ade,glucose products in China, today announced tha... will conduct a conference call,on Friday, May 15,...

Other Medicine News:Health News:Stanford Center on Longevity Releases New Findings About Voter Attitudes on Health Care Reform 2 Health News:Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial 2 Health News:Shengtai Pharmaceutical Schedules 2009 Third Quarter Financial Results and Conference Call 2 Health News:Shengtai Pharmaceutical Schedules 2009 Third Quarter Financial Results and Conference Call 3

Telesso Technologies wins Popular Science Invention Award for its novel peripheral IV catheter Stanford Center on Longevity Releases New Findings About Voter Attitudes on Health Care Reform Zimmer Holdings to Present at Deutsche Bank 34th Annual Health Care Conference Johnson & Johnson to Participate in Deutsche Bank 34th Annual Health Care Conference Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial Shengtai Pharmaceutical Schedules 2009 Third Quarter Financial Results and Conference Call

(Date:11/24/2009)...sciencesCorporationannouncedtodaythattherewillbemu...erationFLT3inhibitor,inAMLatthe51stAmericanSociety...,LA,December5-8,2009.Anoralpresentationwillhighlig...etystudyinadultswithacutemyeloidleukemia(AML).Addi...theeffectofAC220monotherapyandincombinationwithche...

(Date:11/24/2009)...tCall/--EchoTherapeutics,Inc.(OTCBulletinBoard:ECT...MSystemasanon-invasive,wireless,transdermalcontinu...kinPrepSystemfortransdermaldrugdelivery,announcedt...tiveOfficer,willpresentatthe13thAnnualBiotechandSp...YorkSocietyofSecuritiesAnalysts,at2:05onDecember1,...

(Date:11/24/2009)...CardiovascularLLC,aleadingproviderofcardiovascular...eedtwo-yearcontractwithNovation,oneofthenation,sla...eproviderofsurgicaldevicesforbeatingheartcardiacsu...throughOctober31,2012,MAQUETCardiovascularwillbeth...lesuppliestothemembersofVHAInc.andUniversityHealth...

[0] Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting [0] Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference [0] MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices

...ng CIMZIA,s long-term benefits and value in,modera... American College,of Gastroenterology (ACG), ORLA...this week by UCB at the American College of Gastro...IMZIA(R) (certolizumab pegol) - the,only PEGylated...ovides,sustained improvement in symptoms with stab...

... 7 , - 125 Patient, Prospective Randomized Placeb...gnificant Improved Overall Survival, Bavarian Nor...m the,therapeutic prostate cancer vaccine candidat...he recently entered partnership with the National,...om the Phase II prospective randomized placebo-con...

Other Medicine Technology:CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2 CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3 CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4 CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5 CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6 CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7 CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8 CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9 Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2 Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3 Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4 Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 5

CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine

...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...

Medicine Products:

Hepatitis A Virus Antibodies (Total)Heparin Anti-Xa, Low Molecular Weight Heparin HemoQuant, Feces Hemoglobin Not in RBCs

HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Prefe...( BIRMINGHAM Ala. Sept. 14 /- Hea...),Health